HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Liver Biopsy

A liver biopsy is a medical procedure in which a small sample of liver tissue is extracted for examination. It is typically performed to diagnose and evaluate various liver conditions, such as inflammation, fibrosis, or cirrhosis. The procedure aids in determining the extent of liver damage and guiding appropriate treatment plans. There are different methods for conducting a liver biopsy, with the most common being a percutaneous liver biopsy. During this procedure, a thin needle is inserted through the skin and into the liver to obtain a tissue sample. Other methods include transjugular and laparoscopic biopsies, each chosen based on individual patient factors and the specific clinical situation. Liver biopsies are often recommended when blood tests or imaging studies suggest liver abnormalities that cannot be definitively diagnosed without examining tissue directly. The collected liver tissue is then analyzed under a microscope by a pathologist to identify any abnormalities, such as inflammation, fatty liver disease, or the presence of tumors. While liver biopsies provide valuable diagnostic information, they are not without risks. Potential complications include bleeding, infection, or injury to nearby organs. As such, the decision to undergo a liver biopsy is carefully considered by healthcare professionals, taking into account the potential benefits and risks for each patient. In conclusion, a liver biopsy is a crucial diagnostic tool used to assess and understand various liver conditions. Despite its importance, the procedure is not undertaken lightly due to associated risks. The information obtained from a liver biopsy plays a pivotal role in guiding medical interventions and determining the most appropriate course of treatment for individuals with liver disorders.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp